Webinaire en direct « Transcranial Pulse Stimulation (TPS) in Patients with Alzheimer`s Disease » le mercredi 24 mars 2021 · 18:00 - 19:00 (CET)

Webinaire en direct « Transcranial Pulse Stimulation (TPS) in Patients with Alzheimer`s Disease »

Le webinaire en direct « Transcranial Pulse Stimulation (TPS®) in Patients with Alzheimer`s Disease » avec le Prof. Dr Roland Beisteiner sera hébergé par SOTERIX Medical en coopération avec STORZ MEDICAL.

La stimulation transcrânienne par impulsions (TPS®) est une nouvelle technique révolutionnaire qui assure une stimulation par impulsions basée sur les ultrasons à l'aide d'ondes de choc.

Lire la suite
0
  58 lectures
  0 commentaires
58 lectures
0 commentaires

Stimulation transcrânienne par impulsions (TPS) : premier système NEUROLITH installé en Suisse

Premier système NEUROLITH installé en Suisse_Schweiz_01

La stimulation transcrânienne par impulsions (TPS®) pour le traitement des patients atteints de la maladie d’Alzheimer est désormais également disponible pour les patients en Suisse. Début février 2021, le premier système NEUROLITH® a été installé avec succès dans le cabinet du Dr Alexander Russ à Zurich.

Lire la suite
0
  92 lectures
  0 commentaires
Mots-clés :
92 lectures
0 commentaires

Parkinson's disease: World's first clinical trial for shock wave treatment

2020-09-30_news_TPS-enables-targeted-stimulation-of-cerebral-region

In 2019 the NEUROLITH® shock wave system was successfully introduced to the market. The Transcranial Pulse Stimulation (TPS®) device, which was developed by STORZ MEDICAL in Switzerland, is the only medical device marketed in Europe that is approved in the European Union for the treatment of the central nervous system of patients with Alzheimer's disease. The effect of TPS® is now being investigated in another neurological condition: In September 2020, the world's first clinical study for the treatment of Parkinson's patients with shock wave therapy using real-time documentation started at MedUni Vienna (Department of Neurology) in Austria under the direction of Professor Roland Beisteiner.

Lire la suite
0
  1662 lectures
  0 commentaires
1662 lectures
0 commentaires

NEUROLITH installation: in the treatment of patients with Alzheimer’s disease, the »Rudolfinerhaus Privatklinik« in Vienna, Austria, relies on Transcranial Pulse Stimulation (TPS)

2020-07-20_news_NEUROLITH-Installation-Vienna

Throughout the world, more and more specialised medical centres are using Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system for the treatment of patients with Alzheimer’s disease. In June 2020, another NEUROLITH® system was installed successfully at the private hospital »Rudolfinerhaus Privatklinik« in Vienna, Austria, where it will be used under the medical direction of Dr Matthias Geisler. On-site training of the hospital’s treatment team was carried out by Dr Henning Lohse-Busch (Rheintalklinik, Bad Krozingen, Germany) who also played a decisive role in the development of TPS®.

Lire la suite
0
  2022 lectures
  0 commentaires
Mots-clés :
2022 lectures
0 commentaires

Alzheimer’s treatment: study on STORZ MEDICAL’s Transcranial Pulse Stimulation (TPS) is among the top 10% most downloaded papers in Advanced Science

2020-05-26_Top-downloaded-paper

In December 2019, the first study1 on Transcranial Pulse Stimulation (TPS®) with STORZ MEDICAL’s NEUROLITH® system was published in the prestigious journal Advanced Science. In the study, Beisteiner et al. evaluate the TPS® method and present treatment results. The presented data shows that it is possible to improve brain performance with TPS® and that there is a long-term effect.

Lire la suite
0
  2331 lectures
  0 commentaires
2331 lectures
0 commentaires

MEDICA 2019: STORZ MEDICAL presents new innovations NEUROLITH, MAGNETOLITH and redesigned MODULITH SLC

2019-11-26_news_MEDICA

Düsseldorf/Germany: After three fascinating and very interesting days, MEDICA 2019 ended on 21 November. Once again, the world’s leading medical trade fair was a huge success. At STORZ MEDICAL’s exhibition stand in hall 10, the full range of the company’s therapy options was on display – including several innovations. Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system, a unique procedure for patients with Alzheimer's disease, was explained in detail by Dr Rafael Storz, who also answered the visitors’ questions. In addition, the new MAGNETOLITH® for Extracorporeal Magnetotransduction Therapy (EMTT®) and the redesigned MODULITH® SLC were also at the centre of attention. Both devices were unveiled and presented during the trade fair.

Lire la suite
1
  4894 lectures
  0 commentaires
4894 lectures
0 commentaires

STORZ MEDICAL’s NEUROLITH® receives CE approval – Transcranial Pulse Stimulation (TPS) on the central nervous system of patients with Alzheimer’s disease

Neurolith_CE_Approval

In December 2018, STORZ MEDICAL has received the CE approval for the NEUROLITH®, a new therapy system for the treatment of neurological diseases.

Lire la suite
26
  14643 lectures
  0 commentaires
14643 lectures
0 commentaires
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel